$1.550
-0.145 (-9.36%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
XTLB Prediction & Forecast by Similar Chart Analysis
Alphio's XTLB stock price prediction model matches the current X T L Biopharmaceuticals Ltd tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.54 (-0.71%). The 1-week path is $1.53 (-1.26%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy X T L Biopharmaceuticals Ltd Stock?
XTL Biopharmaceuticals Ltd is not a good buy right now due to its current price of $1.55, which is significantly below its 52-week high of $5.64 and reflects a staggering 58.91% decline over the past year. Additionally, the company's RSI is at 28.491, indicating it is oversold, but the lack of positive financial indicators such as a gross margin of 0.00% and a forward P/E of 0 raises serious concerns about its profitability and future growth potential. The main risk is the Nasdaq delisting notice, which could further depress the stock price if not resolved.
XTLB stock price ended at $1.55 on Friday, after losing -9.36%
X T L Biopharmaceuticals Ltd (XTLB) last closed at $1.55, losing -9.36%. These facts feed the 1-day and 1-week XTLB price prediction above.
Forecast Drivers
X T L Biopharmaceuticals Ltd (XTLB) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches XTLB, ranked by similarity.
Seasonality analysis for XTLB
Historically the probability of a positive November return for XTLB is 45.45%. August offers the highest probability of a positive month at 67.19%, while February is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for XTLB
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Nov 2026 | $1.86 | $1.91 | $2.28 | +23.46% |
| Dec 2026 | $2.08 | $2.09 | $2.34 | +34.69% |
In 2026, X T L Biopharmaceuticals Ltd (XTLB) is projected to range from $1.86 to $2.34.
X T L Biopharmaceuticals Ltd 2026 monthly forecast
In Nov 2026, X T L Biopharmaceuticals Ltd is projected to average $1.91, with a low of $1.86 and high of $2.28.
In Dec 2026, X T L Biopharmaceuticals Ltd is projected to average $2.09, with a low of $2.08 and high of $2.34.
Related articles
- CPI Report and the Stock Market: How to Read October 2026 Inflation Data Before the Fed DecidesOctober 2026 CPI lands Nov 10 with no year-over-year number and Fed hike odds near 80%. Learn how to read CPI, which stocks react, and how to plan for it.
- Are You Buying NVIDIA’s Earnings or Its CEO’s Perfect Image?An Alphio analysis of NVIDIA’s share-price timeline, operating results, governance uncertainty and upcoming earnings.
- Stock Market After the 2026 Midterms: What a Democratic Congress Means for InvestorsDemocrats swept Congress in the 2026 midterms. See how stocks reacted, what history says about post-midterm returns, and which sectors face new risks.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.